Acción Reshape Lifesciences (RSLS)
Empresa que cotiza en bolsa. Aquí tienes el precio, un resumen del negocio y lo que conviene saber sobre Reshape Lifesciences en septiembre 2026.
ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The Diabetes Bloc-Stim Neuromodulation system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0 FLEX, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
Sobre esta acción
ReShape Lifesciences Inc
RSLS
Precio actual
$4.77
Beneficio potencial a 12 meses
1,115.93%
Sector
N/A
Industria
N/A
Símbolo
RSLS
Capitalización de mercado
$7.64M
Beneficio potencial a 12 meses
1,115.93%
Sector
N/A
Industria
N/A
Rendimiento del crecimiento a seis meses
Resumen del rendimiento de la acción
Calificación de los analistas
Analysts strongly recommend buying ReShape Lifesciences' stock, with a significant target price of $58.
Salud financiera
ReShape Lifesciences is performing well with strong revenue and cash flow, indicating solid financial health.
Ve más acciones descargando la app GRATIS
Solo toma 60 segundos.
¿Por qué invertir con Nemo?
Cero comisiones
Opera acciones, ETF y más sin comisiones. Conserva una mayor parte de tus ganancias.
Confiable y regulado
Parte del grupo Exinity desde 2015, con más de un millón de clientes en todo el mundo.